Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Male Hypogonadism market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Male Hypogonadismmarket, defines the market attractiveness level of Male Hypogonadism market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Male Hypogonadism industry, describes the types of Male Hypogonadism market, the applications of major players and the market size, and deeply analyzes the current situation of the global Male Hypogonadism market and the development prospects and opportunities of Male Hypogonadism industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Male Hypogonadism market in Chapter 13.
By Player:
AbbVie Inc
Endo International Plc
Merck & Co Inc
Laboratories Genevrier
Teva Pharmaceutical Industries Ltd
Ferring
Astrazeneca Plc
Bayer AG
IBSA Institut Biochimque
Eli Lilly and Company Ltd
Finox Biotech
Allergan Plc
By Type:
Testosterone Replacement Therapy
Gonadotropin-Releasing Hormones Therapy
By End-User:
Kallmann Syndrome
Klinefelters Syndrome
Pituitary Disorders
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Male Hypogonadism Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Male Hypogonadism Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Male Hypogonadism Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Male Hypogonadism Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Male Hypogonadism Market Analysis and Outlook to 2022
-
7.1 Global Male Hypogonadism Consumption (2017-2022)
-
7.2 United States Male Hypogonadism Consumption (2017-2022)
-
7.3 Europe Male Hypogonadism Consumption (2017-2022)
-
7.4 China Male Hypogonadism Consumption (2017-2022)
-
7.5 Japan Male Hypogonadism Consumption (2017-2022)
-
7.6 India Male Hypogonadism Consumption (2017-2022)
-
7.7 South Korea Male Hypogonadism Consumption (2017-2022)
8 Region and Country-wise Male Hypogonadism Market Analysis and Outlook to 2028
-
8.1 Global Male Hypogonadism Consumption Forecast (2022-2028)
-
8.2 United States Male Hypogonadism Consumption Forecast (2022-2028)
-
8.3 Europe Male Hypogonadism Consumption Forecast (2022-2028)
-
8.4 China Male Hypogonadism Consumption Forecast (2022-2028)
-
8.5 Japan Male Hypogonadism Consumption Forecast (2022-2028)
-
8.6 India Male Hypogonadism Consumption Forecast (2022-2028)
-
8.7 South Korea Male Hypogonadism Consumption Forecast (2022-2028)
9 Global Male Hypogonadism Market Outlook by Types and Applications to 2022
-
9.1 Global Male Hypogonadism Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Testosterone Replacement Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Gonadotropin-Releasing Hormones Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Male Hypogonadism Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Kallmann Syndrome Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Klinefelters Syndrome Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Pituitary Disorders Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Male Hypogonadism Market Outlook by Types and Applications to 2028
-
10.1 Global Male Hypogonadism Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Testosterone Replacement Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Gonadotropin-Releasing Hormones Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Male Hypogonadism Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Kallmann Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Klinefelters Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Pituitary Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Male Hypogonadism Import and Export Analysis (Top 5 Countries)
-
11.1 Global Male Hypogonadism Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Male Hypogonadism Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Male Hypogonadism Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Male Hypogonadism Market Competitive Analysis
-
14.1 AbbVie Inc
-
14.1.1 AbbVie Inc Company Details
-
14.1.2 AbbVie Inc Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AbbVie Inc Male Hypogonadism Product and Service
-
14.2 Endo International Plc
-
14.2.1 Endo International Plc Company Details
-
14.2.2 Endo International Plc Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Endo International Plc Male Hypogonadism Product and Service
-
14.3 Merck & Co Inc
-
14.3.1 Merck & Co Inc Company Details
-
14.3.2 Merck & Co Inc Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck & Co Inc Male Hypogonadism Product and Service
-
14.4 Laboratories Genevrier
-
14.4.1 Laboratories Genevrier Company Details
-
14.4.2 Laboratories Genevrier Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Laboratories Genevrier Male Hypogonadism Product and Service
-
14.5 Teva Pharmaceutical Industries Ltd
-
14.5.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.5.2 Teva Pharmaceutical Industries Ltd Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Teva Pharmaceutical Industries Ltd Male Hypogonadism Product and Service
-
14.6 Ferring
-
14.6.1 Ferring Company Details
-
14.6.2 Ferring Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Ferring Male Hypogonadism Product and Service
-
14.7 Astrazeneca Plc
-
14.7.1 Astrazeneca Plc Company Details
-
14.7.2 Astrazeneca Plc Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Astrazeneca Plc Male Hypogonadism Product and Service
-
14.8 Bayer AG
-
14.8.1 Bayer AG Company Details
-
14.8.2 Bayer AG Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bayer AG Male Hypogonadism Product and Service
-
14.9 IBSA Institut Biochimque
-
14.9.1 IBSA Institut Biochimque Company Details
-
14.9.2 IBSA Institut Biochimque Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 IBSA Institut Biochimque Male Hypogonadism Product and Service
-
14.10 Eli Lilly and Company Ltd
-
14.10.1 Eli Lilly and Company Ltd Company Details
-
14.10.2 Eli Lilly and Company Ltd Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Eli Lilly and Company Ltd Male Hypogonadism Product and Service
-
14.11 Finox Biotech
-
14.11.1 Finox Biotech Company Details
-
14.11.2 Finox Biotech Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Finox Biotech Male Hypogonadism Product and Service
-
14.12 Allergan Plc
-
14.12.1 Allergan Plc Company Details
-
14.12.2 Allergan Plc Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Allergan Plc Male Hypogonadism Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Male Hypogonadism
-
Figure Male Hypogonadism Picture
-
Table Global Male Hypogonadism Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Male Hypogonadism Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Male Hypogonadism Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Male Hypogonadism Consumption by Country (2017-2022)
-
Figure United States Male Hypogonadism Consumption and Growth Rate (2017-2022)
-
Table Europe Male Hypogonadism Consumption and Growth Rate (2017-2022)
-
Figure China Male Hypogonadism Consumption and Growth Rate (2017-2022)
-
Figure Japan Male Hypogonadism Consumption and Growth Rate (2017-2022)
-
Figure India Male Hypogonadism Consumption and Growth Rate (2017-2022)
-
Figure South Korea Male Hypogonadism Consumption and Growth Rate (2017-2022)
-
Figure Global Male Hypogonadism Consumption Forecast by Country (2022-2028)
-
Figure United States Male Hypogonadism Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Male Hypogonadism Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Male Hypogonadism Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Male Hypogonadism Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Male Hypogonadism Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Male Hypogonadism Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Testosterone Replacement Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Gonadotropin-Releasing Hormones Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Kallmann Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Klinefelters Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Pituitary Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Testosterone Replacement Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gonadotropin-Releasing Hormones Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kallmann Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Klinefelters Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pituitary Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Male Hypogonadism Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Male Hypogonadism Export by Region (Top 5 Countries) (2017-2028)
-
Table AbbVie Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie Inc Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inc Male Hypogonadism Product and Service
-
Table Endo International Plc (Foundation Year, Company Profile and etc.)
-
Table Endo International Plc Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
Table Endo International Plc Male Hypogonadism Product and Service
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Male Hypogonadism Product and Service
-
Table Laboratories Genevrier (Foundation Year, Company Profile and etc.)
-
Table Laboratories Genevrier Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
Table Laboratories Genevrier Male Hypogonadism Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Male Hypogonadism Product and Service
-
Table Ferring (Foundation Year, Company Profile and etc.)
-
Table Ferring Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ferring Male Hypogonadism Product and Service
-
Table Astrazeneca Plc (Foundation Year, Company Profile and etc.)
-
Table Astrazeneca Plc Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astrazeneca Plc Male Hypogonadism Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Male Hypogonadism Product and Service
-
Table IBSA Institut Biochimque (Foundation Year, Company Profile and etc.)
-
Table IBSA Institut Biochimque Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
Table IBSA Institut Biochimque Male Hypogonadism Product and Service
-
Table Eli Lilly and Company Ltd (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Ltd Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Ltd Male Hypogonadism Product and Service
-
Table Finox Biotech (Foundation Year, Company Profile and etc.)
-
Table Finox Biotech Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
Table Finox Biotech Male Hypogonadism Product and Service
-
Table Allergan Plc (Foundation Year, Company Profile and etc.)
-
Table Allergan Plc Male Hypogonadism Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Plc Male Hypogonadism Product and Service
-
